MIRA INFORM REPORT

Report No. :	497523
Report Date :	16.03.2018

IDENTIFICATION DETAILS

Name :	HEADWORKS BIO INC.
Registered Office :	1999 Bryan ST., STE. 900 Dallas, TX 75201 USA
Country :	United States
Financials (as on) :	2016 [Summarized]
Date of Incorporation :	1993
Legal Form :	Corporation
Line of Business :	Subject offers biological wastewater treatment processes that can be used as secondary treatment for a variety of municipal and industrial applications.
No. of Employees :	30

RATING & COMMENTS

(Mira Inform has adopted New Rating mechanism w.e.f. 23^rd January 2017)

MIRA’s Rating :

A

Credit Rating	Explanation	Rating Comments
A	Acceptable Risk	Business dealings permissible with moderate risk of default

Status :	Satisfactory
Payment Behaviour :	No Complaints
Litigation :	Clear

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List

Country Name	Previous Rating (30.09.2017)	Current Rating (31.12.2017)
United States	A1	A1

Risk Category	ECGC Classification
Insignificant	A1
Low Risk	A2
Moderately Low Risk	B1
Moderate Risk	B2
Moderately High Risk	C1
High Risk	C2
Very High Risk	D

UNITED STATES - ECONOMIC OVERVIEW

The US has the most technologically powerful economy in the world, with a per capita GDP of $57,300. US firms are at or near the forefront in technological advances, especially in computers, pharmaceuticals, and medical, aerospace, and military equipment; however, their advantage has narrowed since the end of World War II. Based on a comparison of GDP measured at purchasing power parity conversion rates, the US economy in 2014, having stood as the largest in the world for more than a century, slipped into second place behind China, which has more than tripled the US growth rate for each year of the past four decades.

In the US, private individuals and business firms make most of the decisions, and the federal and state governments buy needed goods and services predominantly in the private marketplace. US business firms enjoy greater flexibility than their counterparts in Western Europe and Japan in decisions to expand capital plant, to lay off surplus workers, and to develop new products. At the same time, businesses face higher barriers to enter their rivals' home markets than foreign firms face entering US markets.

Long-term problems for the US include stagnation of wages for lower-income families, inadequate investment in deteriorating infrastructure, rapidly rising medical and pension costs of an aging population, energy shortages, and sizable current account and budget deficits.

The onrush of technology has been a driving factor in the gradual development of a "two-tier" labor market in which those at the bottom lack the education and the professional/technical skills of those at the top and, more and more, fail to get comparable pay raises, health insurance coverage, and other benefits. But the globalization of trade, and especially the rise of low-wage producers such as China, has put additional downward pressure on wages and upward pressure on the return to capital. Since 1975, practically all the gains in household income have gone to the top 20% of households. Since 1996, dividends and capital gains have grown faster than wages or any other category of after-tax income.

Imported oil accounts for nearly 55% of US consumption and oil has a major impact on the overall health of the economy. Crude oil prices doubled between 2001 and 2006, the year home prices peaked; higher gasoline prices ate into consumers' budgets and many individuals fell behind in their mortgage payments. Oil prices climbed another 50% between 2006 and 2008, and bank foreclosures more than doubled in the same period. Besides dampening the housing market, soaring oil prices caused a drop in the value of the dollar and a deterioration in the US merchandise trade deficit, which peaked at $840 billion in 2008. Because the US economy is energy-intensive, falling oil prices since 2013 have alleviated many of the problems the earlier increases had created.

The sub-prime mortgage crisis, falling home prices, investment bank failures, tight credit, and the global economic downturn pushed the US into a recession by mid-2008. GDP contracted until the third quarter of 2009, making this the deepest and longest downturn since the Great Depression. To help stabilize financial markets, the US Congress established a $700 billion Troubled Asset Relief Program (TARP) in October 2008. The government used some of these funds to purchase equity in US banks and industrial corporations, much of which had been returned to the government by early 2011. In January 2009, Congress passed and President Barack OBAMA signed a bill providing an additional $787 billion fiscal stimulus to be used over 10 years - two-thirds on additional spending and one-third on tax cuts - to create jobs and to help the economy recover. In 2010 and 2011, the federal budget deficit reached nearly 9% of GDP. In 2012, the Federal Government reduced the growth of spending and the deficit shrank to 7.6% of GDP. US revenues from taxes and other sources are lower, as a percentage of GDP, than those of most other countries.

Wars in Iraq and Afghanistan required major shifts in national resources from civilian to military purposes and contributed to the growth of the budget deficit and public debt. Through 2014, the direct costs of the wars totaled more than $1.5 trillion, according to US Government figures.

In March 2010, President OBAMA signed into law the Patient Protection and Affordable Care Act, a health insurance reform that was designed to extend coverage to an additional 32 million Americans by 2016, through private health insurance for the general population and Medicaid for the impoverished. Total spending on healthcare - public plus private - rose from 9.0% of GDP in 1980 to 17.9% in 2010.

In July 2010, the president signed the DODD-FRANK Wall Street Reform and Consumer Protection Act, a law designed to promote financial stability by protecting consumers from financial abuses, ending taxpayer bailouts of financial firms, dealing with troubled banks that are "too big to fail," and improving accountability and transparency in the financial system - in particular, by requiring certain financial derivatives to be traded in markets that are subject to government regulation and oversight.

In December 2012, the Federal Reserve Board (Fed) announced plans to purchase $85 billion per month of mortgage-backed and Treasury securities in an effort to hold down long-term interest rates, and to keep short-term rates near zero until unemployment dropped below 6.5% or inflation rose above 2.5%. In late 2013, the Fed announced that it would begin scaling back long-term bond purchases to $75 billion per month in January 2014 and further reduce them as conditions warranted; the Fed ended the purchases during the summer of 2014. In 2014, the unemployment rate dropped to 6.2%, and continued to fall to 5.5% by mid-2015, the lowest rate of joblessness since before the global recession began; inflation stood at 1.7%, and public debt as a share of GDP continued to decline, following several years of increases. In December 2015, the Fed raised its target for the benchmark federal funds rate by 0.25%, the first increase since the recession began. With US GDP growth below 2%, the Fed opted to raise rates three times since then, and in mid-June 2017, the range for the target rate stood at 1% to 1.25%.

Source : CIA

STATUTORY INFORMATION
Legal Name:	HEADWORKS BIO INC.
Trade Name:	HEADWORKS BIO INC.
ID:	32038891936
Date Created:	1993
Date Incorporated:	02/13/2009
Legal Address:	1999 Bryan ST., STE. 900 Dallas, TX 75201 USA
Operative Address:	11000 Brittmoore Park DR STE 100 Houston, TX 77041-6939 USA
Telephone:	1.713.647.6667 (TEL) 1.877.647.6667 (TOLL FREE)
Fax:	1.713.647.0999
Legal Form:	Corporation
Email:	hw@headworksintl.com
Registered in:	TEXAS
Website:	www.headworksinternational.com
Contact:	Michele LaNoue, President
Staff:	30
Activity:	NAICS 1: Other Commercial and Service Industry Machinery Manufacturing SIC 1: Sewage Treatment Equipment
Banks:	BANK OF AMERICA
History:
	Headworks® was established in 1993.
	Key Developments OCT 06, 2009 HEADWORKS BIO, INC. AWARDED CONTRACT FOR WASTEWATER SYSTEM ON WORLD'S LARGEST CRUISE SHIP System on the Oasis of the Seas cruise ship will use MBBR and return activated sludge technologies Headworks Bio, Inc. recently announced the signing of a contract with STX Europe in Turku, Finland, for the finalization and commissioning of the Oasis of the Seas Cruise Ship wastewater treatment system. The system uses innovative moving bed bioreactor (MBBR) and return activated sludge technologies. Oasis of the Seas is the world's largest cruise ship, built by STX Europe for Royal Caribbean Intl. It will have capacity for 5,400 guests onboard in 2,700 staterooms with a crew contingent of 2,160 members. All black, grey, galley, food waste and laundry wastewater generated onboard will be treated to a higher quality than the Alaska State Discharge Standards, currently the most stringent in the world. The maiden voyage of this technologically groundbreaking ship is scheduled for December 2009 and all systems will be functional and ready for passengers prior to launch.
PRINCIPAL ACTIVITY
	Headworks BIO Inc. offers biological wastewater treatment processes that can be used as secondary treatment for a variety of municipal and industrial applications.
Products/Services description:	BIOLOGICAL PROCESS MBBR IFAS Biological Nutrient Removal CleanSea® Marine Modular HIT System™ Plant Enhancements & Upgrades Wastewater Reuse Sand Filter MECHANICAL EQUIPMENT
Brands:	Eliminator™ Band Screen Perforator® Screen Transpactor™ Transporter™ Screwpactor™ Spiralman™ Spiralman Plus™ TurboDrum IF™ TurboDrum IH™ TurboDrum IN™ TurboStat™ TurboWash™ TurboTank™
Sales are:	Wholesale
Clients:	Evac Group
Suppliers:	NA
Operations area:	National
The subject employs	30 employees
Payments:	No Complaints
LOCATION
Headquarters :	11000 BRITTMOORE PARK DR STE 100 HOUSTON, TX 77041-6939 USA
Comments on Address:	NA
Branches:	No branches registered
Related Companies:	India Sales Office - Bangalore Phone:+91.96321.26667 E-Mail: India@headworksintl.com MENA Sales Office - Dubai Phone:+ 971.55.602.5376 E-Mail: MENA@headworksintl.com
GROUP STRUCTURE AND SUBSIDIARY COMPANIES
Listed at the stock exchange:	NO
Capital:	NA
Shareholders:	This is a private company. One of its shareholders is: GERALD SEIDL
Management:	DIRECTOR GERALD SEIDL 11000 BRITTMORE PARK DRIVE HOUSTON, TX 77041 DIRECTOR MICHELE LANOUE 11000 BRITTMORE PARK DRIVE HOUSTON, TX 77041
FINANCIAL INFORMATION
	The company does not make its financial statements public. The following information has been provided by private sources:
USD 2016
Sales	2 500 000
Cash flow	Normal
LEGAL FILINGS
PATENTS	Patents by Inventor Strahan Loken Strahan Loken has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO). Moving bed bioreactor carrier Patent number: D645159 Type: Grant Filed: October 27, 2010 Date of Patent: September 13, 2011 Assignee: Headworks Bio Inc. Inventor: Strahan Loken Moving bed bioreactor carrier Patent number: D645160 Type: Grant Filed: October 27, 2010 Date of Patent: September 13, 2011 Assignee: Headworks Bio Inc. Inventor: Strahan Loken Moving bed bioreactor carrier Patent number: D645161 Type: Grant Filed: October 27, 2010 Date of Patent: September 13, 2011 Assignee: Headworks Bio Inc. Inventor: Strahan Loken Bicycle carrier rack Patent number: D663676 Type: Grant Filed: July 14, 2011 Date of Patent: July 17, 2012 Inventors: Strahan Loken, Trevor Harmon
GOVERNMENT CONTRACTS	No records found.
CASES	No records found.
TRADEMARKS	HEADWORKS BIO INC. Trademarks CLEANSEA Marine wastewater treatment units Owned by: HEADWORKS BIO INC. Serial Number: 76246235 ACTIVEFLOAT Wastewater purification unit, namely dissolved air flotation unit Owned by: HEADWORKS BIO INC. Serial Number: 77175745 HYDROXYL Wastewater treatment services Owned by: HEADWORKS BIO INC. Serial Number: 77181660 IFAS Wastewater treatment equipment in the nature of biofilm carriers comprised of high-density polyethylene cylinders that circulate… Owned by: HEADWORKS BIO INC. Serial Number: 78674739 ACTIVECELL Wastewater treatment equipment, namely, plastic units providing high surface area to volume ratio for the purpose of high… Owned by: HEADWORKS BIO INC. Serial Number: 78844326
RENEWAL HISTORY	No records found.
UCC	No records found.
OFAC Sanctions List Search	The company is not listed in the OFAC list.
SUMMARY
	Founded in 1993, Headworks Bio Inc. is a small organization in the service industry machinery manufacturers industry located in Houston, TX. It has 30 full time employees and generates an estimated $2.5M USD in annual revenue. Headworks Inc. is based in Houston, Texas with offices around the world including the USA, Canada, India, and the Middle East.
RISK INFORMATION
DEBTS	Controlled
PAYMENTS	No Complaints
CASH FLOW	Normal
STATUS	Active
INTERVIEW
NAME	Madelaine
POSITION	Assistant
COMMENTS	The person contacted confirmed name, address, management, activity, website and brands.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	INR 64.94
UK Pound	1	INR 90.72
Euro	1	INR 80.32
US Dollar	1	INR 64.94

Note : Above are approximate rates obtained from sources believed to be correct

INFORMATION DETAILS

Analysis Done by :	VAR
Report Prepared by :	TPT

RATING EXPLANATIONS

Credit Rating	Explanation	Rating Comments
A++	Minimum Risk	Business dealings permissible with minimum risk of default
A+	Low Risk	Business dealings permissible with low risk of default
A	Acceptable Risk	Business dealings permissible with moderate risk of default
B	Medium Risk	Business dealings permissible on a regular monitoring basis
C	Medium High Risk	Business dealings permissible preferably on secured basis
D	High Risk	Business dealing not recommended or on secured terms only
NB	New Business	No recommendation can be done due to business in infancy stage
NT	No Trace	No recommendation can be done as the business is not traceable

NB is stated where there is insufficient information to facilitate rating. However, it is not to be considered as unfavourable.

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors are as follows:

· Financial condition covering various ratios

· Company background and operations size

· Promoters / Management background

· Payment record

· Litigation against the subject

· Industry scenario / competitor analysis

· Supplier / Customer / Banker review (wherever available)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.